Tourmaline Bio Inc expected to post a loss of 79 cents a share - Earnings Preview

Tourmaline Bio

09/08/2024 19:54

* Tourmaline Bio Inc  TRML.OQ   TRML.O  is expected
to report
results for the period ending September 30 2024
    * 
    * ​LSEG's mean analyst estimate for Tourmaline Bio Inc is
for a
loss of 79 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 4.6%
in the last three months. ​
    * Wall Street's median 12-month price target for Tourmaline
Bio
Inc is $57.00​, above​ its last closing price of $14.54. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -0.71       -0.71      -0.68     Beat    4.7
 Mar. 31 2024  -0.69       -0.67      -0.55     Beat    17.7
 Dec. 31 2023  -0.72       -0.79      -0.81     Missed  -2.5​
 ​​                                                     
 Mar. 31 2023  -2.90       -3.50      -5.40     Missed  -54.3​
 Dec. 31 2022  -4.72       -4.90      -4.40     Beat    10.2
 Sep. 30 2022  -4.62       -4.57      -4.60     Missed  -0.7
 This summary was machine generated August 9 at 18:54 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)